BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21720992)

  • 1. Radiation therapy for ductal carcinoma in situ: a decision analysis.
    Punglia RS; Burstein HJ; Weeks JC
    Cancer; 2012 Feb; 118(3):603-11. PubMed ID: 21720992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
    Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
    Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates in the treatment of ductal carcinoma in situ of the breast.
    Lebeau A; Kühn T
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):49-58. PubMed ID: 26694830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
    Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
    Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.
    Hillner BE; Desch CE; Carlson RW; Smith TJ; Esserman L; Bear HD
    J Clin Oncol; 1996 Jan; 14(1):70-7. PubMed ID: 8558224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
    Trombetta M; Hall M; Julian TB
    Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    Julien JP; Bijker N; Fentiman IS; Peterse JL; Delledonne V; Rouanet P; Avril A; Sylvester R; Mignolet F; Bartelink H; Van Dongen JA
    Lancet; 2000 Feb; 355(9203):528-33. PubMed ID: 10683002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy.
    Vicini FA; Goldstein NS; Kestin LL
    Ann Oncol; 1999 Aug; 10(8):883-90. PubMed ID: 10509147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
    Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
    Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
    Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
    Li Q; Wang K; Yang L; Wu Q; Zhu W; Li Z; Shi Y; Zhang X; Li H
    Clin Breast Cancer; 2021 Aug; 21(4):360-372. PubMed ID: 33846099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DCIS treated with excision alone using the National Comprehensive Cancer Network (NCCN) guidelines.
    Wehner P; Lagios MD; Silverstein MJ
    Ann Surg Oncol; 2013 Oct; 20(10):3175-9. PubMed ID: 23975306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
    De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.
    Kane RL; Virnig BA; Shamliyan T; Wang SY; Tuttle TM; Wilt TJ
    J Natl Cancer Inst Monogr; 2010; 2010(41):130-3. PubMed ID: 20956816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis.
    Wang SY; Kuntz K; Tuttle T; Kane R
    Breast Cancer Res Treat; 2010 Nov; 124(2):393-402. PubMed ID: 20848183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
    Rakovitch E; Pignol JP; Hanna W; Narod S; Spayne J; Nofech-Mozes S; Chartier C; Paszat L
    J Clin Oncol; 2007 Dec; 25(35):5591-6. PubMed ID: 17984188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.